Dianthus Therapeutics Inc DNTH

‎$‎82.452.84(3.57%)(1D)

• Delayed prices by NASDAQ • in USD

Analyst Forecast

Consensus

Price Target

126.20

Based on analysts who covered DNTH

Invest in Dianthus Therapeutics Inc
Today

Create an eToro account to buy DNTH stock on a secure, user-friendly, multi-asset trading platform.

Dianthus Therapeutics Inc DNTH

Buy DNTH

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Wave Life Sciences Ltd

MAX

*Past performance is not an indication of future results

Jump to:

About DNTH >
How to Buy? >
Top Guides >

The Dianthus Therapeutics Inc share price is stable this week.

The Dianthus Therapeutics Inc share price today is ‎$‎82.45, reflecting a ‎3.57‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of DNTH is ‎$‎3.67B with an average volume in the last three months of 1.02M. The stock has a P/E ratio of -20.05 and a dividend yield of 0%. With the stock’s beta sitting at 1.06

Why invest in stocks on eToro?

Start with ‎$‎50

Low fees

users worldwide

Across 70+ countries

Get Started

DNTH Key Metrics

Market Cap

‎$‎3.67B

Day’s Range

‎$‎79.24 - ‎$‎84.59

52W Range

‎$‎35.73 - ‎$‎87.84

Average Volume (3M)

1.02M

Price-Earnings Ratio

-20.05

Revenue

‎$‎2.04M

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎82.45

EPS

‎$‎-4.11

Beta

1.06

How can I buy Dianthus Therapeutics Inc stocks?

To purchase Dianthus Therapeutics Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Dianthus Therapeutics Inc (DNTH) page and place an order to buy Dianthus Therapeutics Inc.

Buy DNTH

Looking for more information? Check out our guide on Academy.

What Is Dianthus Therapeutics Inc?

Dianthus Therapeutics Inc is a United States-based clinical-stage biotechnology company focused on developing innovative antibody therapeutics for severe autoimmune diseases. The company’s goal is to create improved treatment options for patients with significant unmet medical needs through advanced scientific research.

Serving the healthcare sector, Dianthus Therapeutics Inc specialises in discovering and advancing novel antibodies that target specific components of the complement system. Its approach seeks to develop potential one-time or infrequent dosing regimens to enhance patient care and therapeutic effectiveness.

Stay up to date on the share price of DNTH by adding it to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Dianthus Therapeutics Inc
Today

Create an eToro account to buy DNTH stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Dianthus Therapeutics Inc stock?

The current price of DNTH is ‎$‎82.45.

What is Dianthus Therapeutics Inc’s stock future price target?

The average price target for Dianthus Therapeutics Inc is ‎$‎126.20. Sign up to eToro for detailed analyst forecasts and price targets.

What are analysts’ forecasts for Dianthus Therapeutics Inc?

Analysts offer forecasts for Dianthus Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Dianthus Therapeutics Inc?

The market capitalisation of Dianthus Therapeutics Inc is ‎$‎3.67B

Is Dianthus Therapeutics Inc stock buy, sell or hold?

Based on 10 analysts offering recommendations for DNTH in the last 3 months, the overall consensus is .

Daily Movers

Explore the biggest stocks movers on the market.